| |
| |
|
| Insider
Information: |
Levine James E. |
| Relationship: |
Chief Financial Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
125,834 |
|
|
Indirect Shares
|
50,000 |
|
|
| Direct
Value |
$72,900 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
175,834 |
|
|
| Total
Value |
$72,900 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Diversa Corp |
VRNM |
President & CEO, Direc... |
2013-10-31 |
0 |
2009-05-06 |
0 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
Chief Financial Officer |
2020-11-10 |
65,834 |
2020-11-10 |
50,000 |
Premium* |
|
|
Cardiff Oncology Inc |
CRDF |
Chief Financial Officer |
2022-09-16 |
60,000 |
2021-09-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRDF |
Cardiff Oncology Inc |
Chief Financial Officer |
• – – |
2022-09-16 |
4 |
B |
$1.56 |
$46,710 |
D/D |
30,000 |
60,000 |
2.74 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Chief Financial Officer |
• – – |
2021-09-10 |
4 |
B |
$6.32 |
$194,000 |
D/D |
30,000 |
30,000 |
2.74 |
% |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-11-10 |
4 |
B |
$2.01 |
$100,720 |
I/I |
50,000 |
50,000 |
1.99 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
61,891 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-01-28 |
4 |
OE |
$2.51 |
$17,296 |
D/D |
6,891 |
211,891 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2019-09-24 |
4/A |
B |
$1.91 |
$57,240 |
D/D |
30,000 |
30,000 |
2.74 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2019-09-24 |
4 |
B |
$1.91 |
$57,240 |
D/D |
30,000 |
205,000 |
2.74 |
- |
|
| VRNM |
Diversa Corp |
President & CEO |
• • – |
2013-10-31 |
4 |
D |
$4.00 |
$436,664 |
D/D |
(109,166) |
0 |
0 |
- |
|
| VRNM |
Diversa Corp |
Chief Executive Officer |
• • – |
2012-05-15 |
4 |
B |
$3.65 |
$18,228 |
D/D |
4,994 |
109,166 |
2.81 |
- |
|
| VRNM |
Diversa Corp |
Chief Executive Officer |
• • – |
2011-08-25 |
4 |
B |
$3.18 |
$79,500 |
D/D |
25,000 |
104,172 |
2.81 |
- |
|
| VRNM |
Diversa Corp |
EVP, Chief Executive Officer |
• • – |
2011-08-12 |
4 |
B |
$1.69 |
$42,250 |
D/D |
25,000 |
79,172 |
2.81 |
- |
|
| VRNM |
Diversa Corp |
EVP, Chief Financial Officer |
• – – |
2010-08-16 |
4 |
B |
$2.51 |
$63,127 |
D/D |
25,150 |
54,172 |
2.74 |
- |
|
| VRNM |
Diversa Corp |
EVP, Chief Financial Officer |
• – – |
2010-08-13 |
4 |
B |
$2.50 |
$62,140 |
D/D |
24,856 |
29,022 |
2.74 |
- |
|
| VRNM |
Diversa Corp |
EVP, Chief Financial Officer |
• – – |
2009-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
